Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades

T Efferth, O Kadioglu, MEM Saeed, EJ Seo… - Phytochemistry …, 2021 - Springer
Multidrug resistance is a major factor causing the failure of cancer chemotherapy. Efflux
pumps of the ATP-binding cassette (ABC) transporter family expel a large array of diverse …

Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy

T Efferth, H Miyachi, H Bartsch - Cancer genomics & proteomics, 2007 - cgp.iiarjournals.org
In the present review, we give a short introduction into the history, philosophy and traditional
diagnosis and therapy of Kampo, which has its origins in traditional Chinese medicine. The …

The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells

G Kibria, H Hatakeyama, N Ohga, K Hida, H Harashima - Biomaterials, 2013 - Elsevier
Size of the liposomes (LPs) specially governs its biodistribution. In this study, LPs were
developed with controlled sizes, where variation in LP size dictates the ligand–receptor …

The role of copper in drug-resistant murine and human tumors

S Majumder, S Chatterjee, S Pal, J Biswas, T Efferth… - Biometals, 2009 - Springer
Multidrug resistance (MDR) is still a major threat to successful clinical application of cancer
chemotherapy. Copper plays an important role in biological systems, and copper is also …

Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp

G Kibria, H Hatakeyama, K Akiyama, K Hida… - Biological and …, 2014 - jstage.jst.go.jp
Multi-drug resistance (MDR) of cancers to chemotherapy including doxorubicin (DOX) is
mediated by several factors. To design an effective therapy for the treatment of …

Inhibition of P-glycoprotein at the blood–brain barrier by phytochemicals derived from traditional Chinese medicine

A Mahringer, S Karamustafa, D Klotz… - Cancer Genomics & …, 2010 - cgp.iiarjournals.org
The blood–brain barrier (BBB) is a key determinant for drug transport through brain vessels.
It restricts the pharmacological efficacy in numerous neurological diseases, including brain …

Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals

O Kadioglu, J Cao, MEM Saeed, HJ Greten, T Efferth - Targeted oncology, 2015 - Springer
Epidermal growth factor receptors (EGFR, HER2, HER3) activate signal transduction
pathways involved in cancer proliferation, apoptosis, differentiation, metastasis, and …

Role of transporter genes in cisplatin resistance

VB Konkimalla, B Kaina, T Efferth - In Vivo, 2008 - iv.iiarjournals.org
The 50% inhibitory concentration (IC50) values for cisplatin from 60 cell lines of the National
Cancer Institute (NCI), USA, were correlated with the microarray-based mRNA expression …

Prediction of drug sensitivity and resistance of cancer by protein expression profiling

M Volm, R Koomagi, T Efferth - Cancer genomics & proteomics, 2004 - cgp.iiarjournals.org
Although the statistical probability of therapeutic success is known for larger groups of
cancer patients, the clinical response to chemotherapy of the individual patient remains …

A review of proteomics in cancer research

PS Patel, SD Telang, RM Rawal… - Asian Pac J Cancer …, 2005 - journal.waocp.org
The most functional compartment encoded by the genome is proteome. Therefore study of
proteome ie proteomics is the promising approach in identification, separation and …